Recombinant multi-species PRKD3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRKD3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene belongs to the multigene protein kinase D family of serine/threonine kinases, which bind diacylglycerol and phorbol esters. Members of this family are characterized by an N-terminal regulatory domain comprised of a tandem repeat of cysteine-rich zinc-finger motifs and a pleckstrin domain. The C-terminal region contains the catalytic domain and is distantly related to calcium-regulated kinases. Catalytic activity of this enzyme promotes its nuclear localization. This protein has been implicated in a variety of functions including negative regulation of human airway epithelial barrier formation, growth regulation of breast and prostate cancer cells, and vesicle trafficking. [provided by RefSeq, Jan 2015]
The Alternative Names of target: 4930557O20Rik,5730497N19Rik,EPK2,PKC-NU,PKD3,PRKCN,PRKD3,Pkcnu,Prkcn,Prkd3,Protein kinase C nu type,Protein kinase EPK2,Serine/threonine-protein kinase D3,nPKC-NU,nPKC-nu

Target products collectionGo to PRKD3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6969-Ag-1/ GM-Tg-hg-IP6969-Ag-2 Human PRKD3 protein Human
GM-Tg-rg-IP6969-Ag-1/ GM-Tg-rg-IP6969-Ag-2 Rat PRKD3 protein Rat
GM-Tg-mg-IP6969-Ag-1/ GM-Tg-mg-IP6969-Ag-2 Mouse PRKD3 protein Mouse
GM-Tg-cynog-IP6969-Ag-1/ GM-Tg-cynog-IP6969-Ag-2 Cynomolgus/Rhesus macaque PRKD3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6969-Ag-1/ GM-Tg-felg-IP6969-Ag-2 Feline PRKD3 protein Feline
GM-Tg-cang-IP6969-Ag-1/ GM-Tg-cang-IP6969-Ag-2 Canine PRKD3 protein Canine
GM-Tg-bovg-IP6969-Ag-1/ GM-Tg-bovg-IP6969-Ag-2 Bovine PRKD3 protein Bovine
GM-Tg-equg-IP6969-Ag-1/ GM-Tg-equg-IP6969-Ag-2 Equine PRKD3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6969-Ag-1/ GM-Tg-hg-IP6969-Ag-2; GM-Tg-rg-IP6969-Ag-1/ GM-Tg-rg-IP6969-Ag-2;
GM-Tg-mg-IP6969-Ag-1/ GM-Tg-mg-IP6969-Ag-2; GM-Tg-cynog-IP6969-Ag-1/ GM-Tg-cynog-IP6969-Ag-2;
GM-Tg-felg-IP6969-Ag-1/ GM-Tg-felg-IP6969-Ag-2; GM-Tg-cang-IP6969-Ag-1/ GM-Tg-cang-IP6969-Ag-2;
GM-Tg-bovg-IP6969-Ag-1/ GM-Tg-bovg-IP6969-Ag-2; GM-Tg-equg-IP6969-Ag-1/ GM-Tg-equg-IP6969-Ag-2
Products Name PRKD3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PRKD3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRKD3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.